About Neo-Bionica
Neo-Bionica translates bold, unprecedented ideas into Class III implantable medical devices for human use.
Headquartered in Melbourne, Australia with a team in the USA, we collaborate with pioneering medical technology teams worldwide. We are experts in the critical translation from early-stage invention to robust, clinical-grade manufacture.
We excel where uncertainty is expected, timelines are tight, and the stakes (both technical and commercial) are high. Startups and early-stage ventures turn to us for precision: systems, assemblies, and integrated subsystems that meet demanding feasibility, safety, and early clinical requirements.
We are deeply embedded in the neurotechnology ecosystem. Our team combines domain fluency across systems integration, implantable power systems, electrode fabrication, firmware, and miniaturisation. Layered atop this is our ISO 13485-certified quality system, designed to ensure engineering clarity and regulatory readiness.
Why clients choose Neo-Bionica
✓ 100% dedication to neurotech, leveraging Australia’s cluster of neurotech excellence and track record
✓ Unparalleled Class III device development expertise, covering the full breadth of product development from science to manufacturing establishment
✓ Specifically structured for early-stage neurotechnology ventures
✓ Hospital-integrated for superior clinical collaboration and speed to First-in-Human trials
We optimise for inflection, that moment when a program clearly demonstrates reduced risk. Our model is deliberately lean, responsive, and architected around the capital cadence and milestones of early-stage companies.
Infrastructure designed for clinical-grade output
Our facilities are housed within the St. Vincent’s Hospital Melbourne, providing direct interfaces with clinical collaborators and surgical end-users.
Onsite capabilities include:
ISO-7 certified cleanrooms
Laser seam welding and hermeticity testing
Custom microfabrication and precision machining
High-reliability electronics assembly and validation systems
Rapid prototyping
This environment allows us to accelerate iteration, uphold quality, and anticipate manufacturing issues rapidly.
Why Melbourne? Why Australia?
Melbourne is a global nexus for biomedical innovation, with ready access to clinical partners, academic collaborators, and world-class engineering talent. Plus, eligible start-ups conducting R&D and clinical trials in Australia may qualify for the R&D Tax Incentive, offering a cash refund of up to 43.5% on eligible expenses. For cost-conscious ventures, this can represent a significant and non-dilutive runway extension.
“Neo-Bionica’s expertise, and state-of-the-art facilities have enabled us to develop an advanced prototype and secure $1 million in funding.”
Dr. Emerson Keenan, Founder at Kali Healthcare
The next step
We support founders and teams pursuing genuinely novel neurotechnologies, where stakes are high and pathways are anything but linear.
DISCUSS YOUR DEVICE